NEW

Johnson & Johnson to Acquire Shockwave Medical

Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335 per share in cash, corresponding to an enterprise value of...

Medline Expands Catheter Portfolio

Medline and Consure Medical have announced a new agreement for Medline to exclusively distribute the QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD)....

FDA Clears Single-use Flexible Ureteroscope

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later...

Brainlab, Fujifilm Offer Advanced Neurosurgery Capabilities

FUJIFILM Healthcare Americas Corporation and Brainlab recently announced that Brainlab will be the exclusive U.S. distributor of ARIETTA Precision Ultrasound for neurosurgery applications to be utilized with Brainlab’s surgical navigation systems. ARIETTA Precision,...

ECRI Institute Launches Health Care Horizon Scanning System

ECRI Institute, an independent trusted authority on healthcare practices and products, received a 3-year contract to establish and operate a new health care horizon scanning system for the Patient-Centered Outcomes Research Institute (PCORI).

The Health Care Horizon Scanning System will help patients, clinicians, researchers, payers, and policy makers identify at an early stage new therapeutics and healthcare technologies that have the potential to be disruptive. Initially, the focus will be on interventions for patients with Alzheimer’s disease and other dementias, cancer, cardiovascular conditions, mental and behavioral health conditions, and rare diseases. PCORI may choose to add additional clinical areas for horizon scanning in the future.

“Every day we hear about new technologies that may lead to breakthroughs in medical science and patient care,” says Karen Schoelles, MD, SM, FACP, vice president for clinical excellence and safety at ECRI Institute. “We are excited to provide insights to help PCORI understand the need for future comparative effectiveness research and help other stakeholders plan for disruptive change.”

ECRI Institute will use advanced search methodology to identify, track, monitor, and evaluate health care interventions in research and development up to 3 years before they are expected to enter routine clinical care. Additionally, clinicians, health systems administrators, researchers, patients, and caregivers will be asked to contribute their unique perspectives. Their perspectives will help ECRI Institute assess the potential for these interventions to improve patient care, health care delivery processes, and reduce cost of care in the United States.

ECRI Institute ran the first U.S. healthcare horizon scanning system from 2010 to 2015 through a contract with the Agency for Healthcare Research and Quality (AHRQ).

The Protocol and Operations Manual for the Health Care Horizon Scanning System is available on the PCORI website. For more information, visit www.ecri.org, call +1 (610) 825-6000; or e-mail communications@ecri.org.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X